Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current concepts of malignant hyperthermia.

B W Jafek, C C Solomons, N C Masson

    Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
    |November 1, 1981
    PubMed
    Summary

    Malignant hyperthermia (MH) is a genetic disorder triggered by anesthesia, causing severe symptoms. A new test can identify susceptible individuals, and dantrolene sodium can prevent or treat MH.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fast and accurate measurement of taste and smell thresholds using a maximum-likelihood adaptive staircase procedure.

    Perception & psychophysics·2002
    Same author

    A modification of the midface degloving technique.

    The Laryngoscope·1999
    Same author

    Recurrent psychogenic coma following tracheal stenosis repair.

    Archives of otolaryngology--head & neck surgery·1999
    Same author

    An optimal choice: home intravenous hydration after tonsillectomy.

    The Laryngoscope·1997
    Same author

    Protein gene product 9.5-like and calbindin-like immunoreactivity in the nasal respiratory mucosa of perinatal humans.

    The Anatomical record·1997
    Same author

    Physician workforce in otolaryngology.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1996

    Area of Science:

    • Anesthesiology
    • Genetics
    • Pharmacology

    Background:

    • Malignant hyperthermia (MH) is a pharmacogenetic disorder.
    • It is a life-threatening condition triggered by specific anesthetic agents.
    • MH affects individuals with a genetic susceptibility.

    Observation:

    • MH presents with hypermetabolism, muscle rigidity, and hyperthermia.
    • Symptoms typically manifest during or shortly after anesthesia.
    • The incidence is approximately 1:15,000 in general anesthetic recipients.

    Findings:

    • A novel platelet bioassay enables rapid identification of MH-susceptible individuals.
    • Dantrolene sodium is an effective therapeutic agent for MH.
    • Early diagnosis and treatment are crucial for patient outcomes.

    Related Experiment Videos

    Implications:

    • Improved diagnostic tools enhance patient safety in anesthesia.
    • Pharmacogenetic testing can guide anesthetic choices.
    • Timely intervention with dantrolene sodium can prevent MH-related mortality.